The PARP inhibitor ABT-888 synergizes irinotecan treatment of colon cancer cell lines.
about
Beyond Breast and Ovarian Cancers: PARP Inhibitors for BRCA Mutation-Associated and BRCA-Like Solid TumorsRationale for poly(ADP-ribose) polymerase (PARP) inhibitors in combination therapy with camptothecins or temozolomide based on PARP trapping versus catalytic inhibition.Regulators of homologous recombination repair as novel targets for cancer treatment.Influence of PJ34 on the genotoxicity induced by melphalan in human multiple myeloma cells.Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of the Poly(ADP-ribose) Polymerase (PARP) Inhibitor Veliparib (ABT-888) in Combination with Irinotecan in Patients with Advanced Solid TumorsThe PARP inhibitor ABT-888 potentiates dacarbazine-induced cell death in carcinoids.A comprehensive look of poly(ADP-ribose) polymerase inhibition strategies and future directions for cancer therapy.Dovitinib enhances temozolomide efficacy in glioblastoma cells.Simultaneous inhibition of ATR and PARP sensitizes colon cancer cell lines to irinotecan.A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumours.
P2860
Q26852274-F6E42A8C-F3E0-421B-AF97-412490D44F03Q33603605-0210A8B0-40D6-4AF0-B692-F88216321F9EQ35200273-9DD31942-EF6C-49DB-9B20-0E8E6055DBC8Q35582803-256D83BD-D0E8-46B4-ACDD-BF773C33B065Q37059846-0E881939-3B59-4F53-8BF6-F1571737686CQ37372483-C4B4A9C3-FDAD-40AE-9AC7-E37699031694Q38780396-970028DA-8742-46A9-952B-2CC0C0371F79Q40214485-CC2EA934-4760-409D-9261-B68A9C2445A3Q42130288-C94004DE-37F3-49B8-9420-01576DCF2B52Q52807922-0F1E3F85-DF9C-4D2B-A626-15916F9BF3A9
P2860
The PARP inhibitor ABT-888 synergizes irinotecan treatment of colon cancer cell lines.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The PARP inhibitor ABT-888 synergizes irinotecan treatment of colon cancer cell lines.
@en
The PARP inhibitor ABT-888 synergizes irinotecan treatment of colon cancer cell lines.
@nl
type
label
The PARP inhibitor ABT-888 synergizes irinotecan treatment of colon cancer cell lines.
@en
The PARP inhibitor ABT-888 synergizes irinotecan treatment of colon cancer cell lines.
@nl
prefLabel
The PARP inhibitor ABT-888 synergizes irinotecan treatment of colon cancer cell lines.
@en
The PARP inhibitor ABT-888 synergizes irinotecan treatment of colon cancer cell lines.
@nl
P2093
P2860
P1476
The PARP inhibitor ABT-888 synergizes irinotecan treatment of colon cancer cell lines.
@en
P2093
David Davidson
Lawrence Panasci
Raquel Aloyz
Yunzhe Wang
P2860
P2888
P304
P356
10.1007/S10637-012-9886-7
P577
2012-10-09T00:00:00Z
P5875
P6179
1007333132